With a faster, more reliable and lower-cost solution, Elegen and Nutcracker Therapeutics aim to democratize PCTs, making them accessible to more developers and saving critical time for cancer patients ...

Download this article to explore how scientists engaged in early cancer diagnostics research can maximize methylation ...

Combining AI-driven design with rapid, cell-free DNA synthesis, researchers are turning mRNA into a scalable solution for vaccines, cancer treatments, and personalized genetic therapies.

This technique, called volumetric DNA microscopy, creates a 3D image of an entire organism from the inside out, giving scientists an unprecedented view of genetic sequences and where they are ...

Study: Evaluation of cell-free DNA approaches for multi-cancer early detection. Image Credit: CI Photos/Shutterstock An MCED test is a blood test that helps early detection of a shared cancer ...

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...

Cell-free DNA analysis of maternal plasma is easy ,non- invasive and highly effective in detecting fetal chromosomal and genetic abnormalities in antenatal mothers ...

A cell-free DNA (cfDNA) blood test, aimed at detecting abnormal DNA signals in people with an average risk of colorectal cancer (CRC), correctly detected CRC in most people confirmed to have the ...

Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...